Mobia Medical Announces Pricing of Initial Public Offering
HealthcareTexasOther
Mobia Medical
May 8, 2026
Lupin Completes VISUfarma Acquisition for Eye Care
Closed
HealthcareAdd-on
Deal Overview
Lupin has completed its acquisition of VISUfarma through a Netherlands subsidiary. The deal expands Lupin’s eye care portfolio to 60+ products.
The transaction is structured as an add-on within Lupin’s ophthalmology business, with VISUfarma’s product line integrated into Lupin’s existing portfolio.
Key Details
- Transaction
- Lupin acquires VISUfarma
Related Deals
Stryker completes acquisition of Amplitude Vascular Systems - MassDevice
HealthcareAdd-on
Stryker→Amplitude Vascular Systems
May 8, 2026
Odyssey, on second try, snags $279M in an IPO
HealthcareNew YorkOther
Odyssey Therapeutics
May 8, 2026
Odyssey Therapeutics Announces Pricing of Upsized Initial Public Offering
HealthcareMassachusettsOther
Odyssey Therapeutics
May 8, 2026
Angelini Pharma’s $4B Acquisition Adds Rare Disease Drugs to a Global Growth Strategy
HealthcarePlatform
Angelini Pharma→Catalyst Pharmaceuticals
May 7, 2026